Escalated Oxycodone Self-Administration Causes Differential Striatal mRNA Expression of FGFs and IEGs Following Abstinence-Associated Incubation of Oxycodone Craving

Neuroscience. 2019 Sep 1:415:173-183. doi: 10.1016/j.neuroscience.2019.07.030. Epub 2019 Jul 24.

Abstract

Addiction to prescribed opioids including oxycodone has reached tragic levels. Herein, we investigated the relevance of fibroblast growth factors (FGFs) and immediate early genes (IEGs) to withdrawal-induced incubation of drug craving following escalated oxycodone self-administration (SA). Rats were trained to self-administer oxycodone for 4 weeks. Seeking tests were performed at various intervals during 1 month of drug withdrawal. Rats were euthanized 1 day after the last test and nucleus accumbens and dorsal striata were dissected for use in PCR analyses. Rats given long access (LgA, 9 h), but not short access (ShA, 3 h) to drug escalated their oxycodone intake and exhibited incubation of oxycodone seeking during withdrawal. These rats exhibited dose-dependent increases in fgf2 expression in the dorsal striatum. Fgfr2 expression was also significantly increased in the striatum in LgA, but not ShA groups. Similarly, striatal c-fos and junB mRNA levels showed greater increases in LgA rats. The observations that fgf mRNA levels were more altered in the dorsal striatum than in the NAc of LgA rats suggest that changes in striatal FGF expression may be more salient to incubation of oxycodone craving than alterations in the NAc. Targeting FGF signaling pathways might offer novel strategies against opioid addiction.

Keywords: addiction; dorsal striatum; glia; incubation; opioids; relapse.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Animals
  • Behavior, Addictive
  • Corpus Striatum / metabolism
  • Craving
  • Fibroblast Growth Factors / drug effects*
  • Fibroblast Growth Factors / metabolism
  • Genes, Immediate-Early / drug effects*
  • Male
  • Models, Animal
  • Nucleus Accumbens / metabolism
  • Opioid-Related Disorders / metabolism*
  • Oxycodone / administration & dosage
  • Oxycodone / metabolism*
  • RNA, Messenger
  • Rats
  • Rats, Sprague-Dawley
  • Self Administration
  • Substance Withdrawal Syndrome

Substances

  • RNA, Messenger
  • Fibroblast Growth Factors
  • Oxycodone